Related Experiment Videos

[Present-day status of glycogenosis Ib. Report of a new case]

V Morena Hinojosas1, A Fullana Montoro, J Alvarez-Coca González

  • 1Servicio de Endocrinología Pediátrica, Hospital Infantil La Paz, Madrid.

Insights

Glycogen storage disease type Ib (GSD-Ib) in infants presents with severe metabolic issues and neutropenia. Early nutritional intervention, including continuous enteral feeding, significantly improves symptoms and metabolic control in affected children.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Genetics

Background:

  • Glycogen storage disease type I (GSD-I) encompasses a group of inherited metabolic disorders affecting glycogen metabolism.
  • GSD-I is characterized by the inability to release glucose from glycogen stores, leading to hypoglycemia and metabolic derangements.

Observation:

  • A four-month-old boy presented with hepatomegaly, lactic acidosis, fasting hypoglycemia, failure to thrive, recurrent infections, and cyclic neutropenia.
  • Impaired immunoglobulin levels and neutrophil chemotaxis were noted.
  • Liver biopsy revealed increased glycogen in hepatocytes, with normal activity of key glycogenolytic enzymes, including glucose-6-phosphatase.

Findings:

  • The clinical and biochemical profile, particularly the normal enzyme activity in the liver, pointed towards a diagnosis of GSD-Ib.
  • Nutritional management, initially continuous enteral feeding and later combined daytime meals with nighttime enteral feeding, effectively resolved hypoglycemia and other metabolic abnormalities.

Implications:

  • This case highlights the importance of considering GSD-Ib in infants with unexplained hypoglycemia, hepatomegaly, and neutropenia.
  • Aggressive nutritional support is crucial for managing the metabolic complications of GSD-Ib.
  • Further research into the specific enzyme deficiencies and genetic basis of GSD-Ib is warranted.

Related Concept Videos